会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • N-Substituted aziridine-2-carboxylic acid derivatives and
immuno-stimulation composition and method
    • N-取代的氮丙啶-2-羧酸衍生物和免疫刺激组合物和方法
    • US4409236A
    • 1983-10-11
    • US268964
    • 1981-06-01
    • Elmar BosiesHerbert BergerWolfgang KampeUwe BickerAlfred Grafe
    • Elmar BosiesHerbert BergerWolfgang KampeUwe BickerAlfred Grafe
    • C07D203/08A61K31/395A61K31/396A61K31/40A61K31/44A61K31/4427A61K31/443A61K31/4433A61P37/04C07D203/06C07D401/04C07D403/06C07D405/04C07D409/04C07D333/30
    • C07D203/06Y10S514/885
    • Aziridine-2-carboxylic acid derivatives of the formula ##STR1## wherein X is a carboxyl, nitrile, alkoxycarbonyl or carbamoyl group, andR and R.sup.1 are various organic radicals; or pharmacologically acceptable salts thereof, exhibit marked immunostimulant activity, especially in conjunction with added chemotherapeutic agents such as a penicillin, a cephalosporin, a nitrofuran or chloramphenicol. Those compounds are new where X is a cyano group or an alkoxycarbonyl radical and R.sub.1 is a hydrogen atom, but R' is not an unsubstituted alkyl radical or an alkyl radical substituted by hydroxyl, alkoxy, dialkylamino, phenyl, 4-chlorophenyl or 4-methoxyphenyl or a vinyl radical substituted by a phenyl or methyl radical, or a cycloalkyl radical, a phenyl, a 4-chlorophenyl, a 4-methoxyphenyl, an s-triazinyl or a pyridinyl radical; or where X is a carbamoyl group and R.sub.1 is a hydrogen atom, R' is not an unsubstituted cyclohexyl, alkyl or benzyl radical; or where X is a cyano group or an alkoxycarbonyl radical and R.sub.1 is a phenyl radical, R' is not an isopropyl, cyclohexyl, phenyl, benzyl or p-chlorobenzyl radical; or where R.sub.1 is a methyl radical, R.sup.1 is not a benzyl, p-chloro- or p- methoxybenzyl radical.
    • 其中X是羧基,腈,烷氧基羰基或氨基甲酰基,R和R 1是各种有机基团; 或其药理学上可接受的盐具有显着的免疫刺激活性,特别是与添加的化学治疗剂如青霉素,头孢菌素,硝基呋喃或氯霉素结合使用。 那些化合物是新的,其中X是氰基或烷氧基羰基,R 1是氢原子,但R'不是未取代的烷基或被羟基,烷氧基,二烷基氨基,苯基,4-氯苯基或4- 甲氧基苯基或被苯基或甲基取代的乙烯基,或环烷基,苯基,4-氯苯基,4-甲氧基苯基,s-三嗪基或吡啶基; 或其中X为氨基甲酰基,R 1为氢原子,R'为未取代的环己基,烷基或苄基; 或其中X为氰基或烷氧基羰基,R 1为苯基,R'不为异丙基,环己基,苯基,苄基或对氯苄基; 或其中R 1是甲基,R 1不是苄基,对氯或对甲氧基苄基。
    • 5. 发明授权
    • N-Substituted aziridine-2-carboxylic acid derivatives for immuno
stimulation
    • N-取代的氮丙啶-2-羧酸衍生物用于免疫刺激
    • US4321194A
    • 1982-03-23
    • US59863
    • 1979-07-23
    • Elmar BosiesHerbert BergerWolfgang KampeUwe BickerAlfred Grafe
    • Elmar BosiesHerbert BergerWolfgang KampeUwe BickerAlfred Grafe
    • C07D203/08A61K31/395A61K31/396A61K31/40A61K31/44A61K31/4427A61K31/443A61K31/4433A61P37/04C07D203/06C07D401/04C07D403/06C07D405/04C07D409/04C07D203/10C07D203/12C07D203/14
    • C07D203/06Y10S514/885
    • Aziridine-2-carboxylic acid derivatives of the formula ##STR1## wherein X is a carboxyl, nitrile, alkoxycarbonyl or carbamoyl group, andR and R.sup.1 are various organic radicals, or pharmacologically acceptable salts thereof, exhibit marked immunostimulant activity, especially in conjunction with added chemotherapeutic agents such as a penicillin, a cephalosporin, a nitrofuran or chloramphenicol. Those compounds are new where X is a cyano group or an alkoxycarbonyl radical and R.sub.1 is a hydrogen atom, but R' is not an unsubstituted alkyl radical or an alkyl radical substituted by hydroxyl, alkoxy, dialkylamino, phenyl, 4-chlorophenyl or 4-methoxyphenyl or a vinyl radical substituted by a phenyl or methyl radical, or a cycloalkyl radical, a phenyl a 4-chlorophenyl, a 4-methoxyphenyl, an s-triazinyl or a pyridinyl radical; or where X is a carbamoyl group and R.sub.1 is a hydrogen atom, R' is not an unsubstituted cyclohexyl, alkyl or benzyl radical; or where X is a cyano group or an alkoxycarbonyl radical and R.sub.1 is a phenyl radical, R' is not an isopropyl, cyclohexyl, phenyl, benzyl or p-chlorobenzyl radical; or where R.sub.1 is a methyl radical, R.sup.1 is not a benzyl, p-chloro- or p- methoxybenzyl radical.
    • 其中X是羧基,腈,烷氧基羰基或氨基甲酰基的氮杂环丁烷-2-羧酸衍生物,R和R 1是各种有机基团或其药理学上可接受的盐,具有显着的免疫刺激活性,特别是与 添加化学治疗剂如青霉素,头孢菌素,硝基呋喃或氯霉素。 那些化合物是新的,其中X是氰基或烷氧基羰基,R 1是氢原子,但R'不是未取代的烷基或被羟基,烷氧基,二烷基氨基,苯基,4-氯苯基或4- 甲氧基苯基或被苯基或甲基取代的乙烯基,或环烷基,苯基,4-氯苯基,4-甲氧基苯基,s-三嗪基或吡啶基; 或其中X为氨基甲酰基,R 1为氢原子,R'为未取代的环己基,烷基或苄基; 或其中X为氰基或烷氧基羰基,R 1为苯基,R'不为异丙基,环己基,苯基,苄基或对氯苄基; 或其中R 1是甲基,R 1不是苄基,对氯或对甲氧基苄基。
    • 7. 发明授权
    • N-Substituted aziridine-2-carboxylic acid derivatives
    • US4517183A
    • 1985-05-14
    • US495548
    • 1983-05-17
    • Elmar BosiesWolfgang KampeMax ThielUwe BickerDietmar Boerner
    • Elmar BosiesWolfgang KampeMax ThielUwe BickerDietmar Boerner
    • A61K31/395A61K31/396A61K31/44A61K31/4427A61K31/443A61K31/505A61P35/00A61P37/00A61P37/06C07D203/22C07D401/12C07D403/12C07D405/12
    • C07D203/22Y10S514/885
    • The present invention provides pharmaceutical compositions containing N-substituted aziridine-2-carboxylic acid derivatives of the general formula: ##STR1## wherein X is a carboxyl, a cyano, an alkoxycarbonyl or an optionally substituted carbamoyl radical, R is a hydrogen atom, an aliphatic hydrocarbon radical which is saturated or can contain one or more unsaturations and can be substituted one or more times by halogen, alkoxy, hydroxyl, dialkylamino, dialkylaminoxy, cycloalkylamino, acylamino, acyl, nitro, alkylthio, alkylsulphinyl, alkylsulphonyl, cyano, carboxyl, alkoxycarbonyl or carbamoyl or by cycloalkyl or cycloalkenyl radicals optionally carrying alkyl, alkoxy or alkoxycarbonyl radicals, optionally interrupted by hetero atoms and optionally bridged, or by an aryl, hetaryl, aryloxy, arylthio, acyloxy, alkoxycarbonylamino or isothioureido radical, or R is a cycloalkyl or cycloalkenyl radical optionally substituted by alkyl, alkoxy or oxo groups, optionally interrupted by hetero atoms and optionally bridged, or is an aryl or hetaryl radical which can be substituted one or more times by halogen, alkoxy, alkyl, hydroxyl, alkoxycarbonyl, carbamoyl, dialkylamino, cycloalkylamino, acylamino, nitro, cyano, acyl, alkylthio, alkylsulphinyl, alkylsulphonyl, sulphamoyl, phenyl, trifluoromethyl, aryloxy, acyloxy or methylenedioxy radicals and R.sub.1 is a hydrogen atom or an alkyl or phenyl radical; and the pharmacologically acceptable salts thereof, in admixture with a pharmaceutical diluent or carrier. The present invention also provides, as new compounds, N-substituted aziridine-2-carboxylic acid derivatives of general formula (I') but with the proviso that when X is a carbamoyl or alkoxycarbonyl radical and R.sub.1 is a hydrogen atom, R is not a methyl, ethyl, isopropyl or benzyl radical; and the pharmacologically acceptable salts thereof, and also provides processes for the preparation of these new compounds. Furthermore, the present invention is concerned with the use of the compounds of general formula (I') and of the pharmacologically acceptable salts thereof for combating diseases associated with a weakening of the immune system.
    • 9. 发明授权
    • N-Substituted aziridine-2-carboxylic acid immunostimulant derivatives
    • N-取代的氮丙啶-2-羧酸免疫刺激剂衍生物
    • US4397848A
    • 1983-08-09
    • US236375
    • 1981-02-20
    • Elmar BosiesWolfgang KampeMax ThielUwe BickerDietmar Boerner
    • Elmar BosiesWolfgang KampeMax ThielUwe BickerDietmar Boerner
    • A61K31/395A61K31/396A61K31/44A61K31/4427A61K31/443A61K31/505A61P35/00A61P37/00A61P37/06C07D203/22C07D401/12C07D403/12C07D405/12
    • C07D203/22Y10S514/885
    • The present invention provides pharmaceutical compositions containing N-substituted aziridine-2-carboxylic acid derivatives of the general formula: ##STR1## wherein X is a carboxyl, a cyano, an alkoxycarbonyl or an optionally substituted carbamoyl radical, R is a hydrogen atom, or an optionally substituted aliphatic hydrocarbon radical or cycloalkyl or cycloalkenyl radical, and R.sub.1 is a hydrogen atom or an alkyl or phenyl radical; and the pharmacologically acceptable salts thereof, in admixture with a pharmaceutical diluent or carrier. The present invention also provides, as new compounds, N-substituted aziridine-2-carboxylic acid derivatives of general formula (I') but with the proviso that when X is a carbamoyl or alkoxycarbonyl radical and R.sub.1 is a hydrogen atom, R is not a methyl, ethyl, isopropyl or benzyl radical; and the pharmacologically acceptable salts thereof, and also provides processes for the preparation of these new compounds. Furthermore, the present invention is concerned with the use of the compounds of general formula (I') and of the pharmacologically acceptable salts thereof for combating diseases associated with a weakening of the immune system.
    • 本发明提供含有下列通式的N-取代的氮丙啶-2-羧酸衍生物的药物组合物:其中X是羧基,氰基,烷氧基羰基或任选取代的氨基甲酰基,R是 氢原子或任选取代的脂族烃基或环烷基或环烯基,R 1为氢原子或烷基或苯基; 和其药学上可接受的盐,与药物稀释剂或载体混合。 本发明还提供了作为新化合物的通式(I')的N-取代的氮丙啶-2-羧酸衍生物,但条件是当X是氨基甲酰基或烷氧基羰基并且R 1是氢原子时,R不是 甲基,乙基,异丙基或苄基; 及其药理学上可接受的盐,也提供制备这些新化合物的方法。 此外,本发明涉及通式(I')的化合物及其药理学上可接受的盐在与免疫系统的弱化相关的疾病中的用途。
    • 10. 发明授权
    • 2-Cyanoaziridinyl-(1)-2-substituted-aziridinyl-(1)-methanes
    • 2-氰基氮丙啶基 - (1)-2-取代的吖丙啶基 - (1) - 甲烷
    • US4370323A
    • 1983-01-25
    • US776068
    • 1977-03-09
    • Wolfgang KampeMax ThielErich FaulandUwe BickerGottfried Hebold
    • Wolfgang KampeMax ThielErich FaulandUwe BickerGottfried Hebold
    • C07D203/06A61K31/395A61K31/396A61K31/435A61P35/00A61P37/04C07D203/08C07D203/12C07D203/14C07D333/00C07D335/00C07D403/14C07D405/14C07D409/14C07D451/14C07D403/06C07D401/14
    • C07D203/08C07D451/14Y10S514/885
    • A 2-cyanoaziridinyl-(1)-2-substituted-aziridinyl-(1)-methane ##STR1## wherein R is a nitrile or carbamoyl group, andR.sub.1 and R.sub.2 each independently is a hydrogen atom, an aliphatic hydrocarbon radical containing up to 10 carbon atoms optionally substituted by hydroxyl, alkoxy, amino, alkylamino, dialkylamino, alkoxycarbonyl, cyano, 1, 2 or 3 halogens, cycloalkyl, phenyl or phenoxy; nitrile, carboxyl, alkoxycarbonyl or optionally hydrogenated monocyclic heteroaryl or phenyl optionally substituted by alkyl, alkoxy, hydroxy, alkoxcarbonyl, dialkylamino, alkylthio, trifluoromethyl, nitro, carbamoyl, nitrile, sulphonamido, hydroxyalkyl, methylenedioxy, or halogen; or R.sub.1 and R.sub.2, together with the carbon atom to which they are attached, form a ring containing up to 8 ring members of which at least one may be oxygen, sulphur, SO, SO.sub.2 NH, N-alkyl, N-acyl or N-alkoxycarbonylalkyl, and which can be substituted by alkyl, alkoxy, hydroxyl, alkylenedioxy, alkoxycarbonyl, hydroxyalkyl, alkoxycarbonylalkyl, dialkylamino, oxo or 2-cyanoaziridino groups, or can be fused to 1 or 2 benzene rings or can be bridged by alkylene radicals containing up to 3 carbon atoms.The compounds are characterized by cytostatic and immune response-stimulating activity.
    • 2-氰基氮丙啶基 - (1)-2-取代的吖丙啶基 - (1) - 甲烷,其中R是腈或氨基甲酰基,R 1和R 2各自独立地为氢原子,含有至多 任选被羟基,烷氧基,氨基,烷基氨基,二烷基氨基,烷氧基羰基,氰基,1,2或3卤素,环烷基,苯基或苯氧基取代的10个碳原子; 腈,羧基,烷氧基羰基或任选氢化的单环杂芳基或任选被烷基,烷氧基,羟基,烷氧基羰基,二烷基氨基,烷硫基,三氟甲基,硝基,氨基甲酰基,腈,磺酰胺基,羟烷基,亚甲二氧基或卤素取代的苯基。 或R 1和R 2与它们所连接的碳原子一起形成含有至多8个环成员的环,其中至少一个可以是氧,硫,SO,SO 2 + L,NH,N-烷基, 酰基或N-烷氧基羰基烷基,其可以被烷基,烷氧基,羟基,亚烷基二氧基,烷氧基羰基,羟基烷基,烷氧基羰基烷基,二烷基氨基,氧代或2-氰基氮丙啶基取代,或者可以与1或2个苯环稠合,或可以被 含有至多3个碳原子的亚烷基。 该化合物的特征在于细胞抑制和免疫应答刺激活性。